Bacterial strains responsible for antibiotic resistant infections are increasing in an alarming way and the evolution of resistance mechanisms seems to be unstoppable. In the past decade, many efforts have been made in order to counteract this phenomenon but very few compounds have reached clinical trials. The development of new classes of antibiotics able to overcome the main bacterial drug resistance mechanisms is urgently required to counter the imminent danger of a postantibiotic era.
Parrino B., Carbone D., Cirrincione G., Diana P., Cascioferro S. (2020). Inhibitors of antibiotic resistance mechanisms: clinical applications and future perspectives. FUTURE MEDICINAL CHEMISTRY, 12(5), 357-360 [10.4155/fmc-2019-0326].
Inhibitors of antibiotic resistance mechanisms: clinical applications and future perspectives
Parrino B.;Carbone D.;Cirrincione G.;Diana P.;Cascioferro S.
2020-01-01
Abstract
Bacterial strains responsible for antibiotic resistant infections are increasing in an alarming way and the evolution of resistance mechanisms seems to be unstoppable. In the past decade, many efforts have been made in order to counteract this phenomenon but very few compounds have reached clinical trials. The development of new classes of antibiotics able to overcome the main bacterial drug resistance mechanisms is urgently required to counter the imminent danger of a postantibiotic era.
| File | Dimensione | Formato | |
|---|---|---|---|
|
fmc-Editorial.pdf
accesso aperto
Descrizione: Editoriale
Tipologia:
Versione Editoriale
Dimensione
155.96 kB
Formato
Adobe PDF
|
155.96 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
